What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary areas of study are Randomized controlled trial, Internal medicine, Surgery, Intensive care medicine and Meta-analysis.
In his study, Physical therapy, Resuscitation and Evidence-based medicine is strongly linked to Clinical trial, which falls under the umbrella field of Randomized controlled trial.
In his research, Lung injury is intimately related to Oncology, which falls under the overarching field of Internal medicine.
Dean Fergusson studied Surgery and Anesthesia that intersect with Relative risk, Red blood cell and Head injury.
His Intensive care medicine research also works with subjects such as
- Blood transfusion together with Cardiac surgery and Adverse effect,
- Cohort study and related Prospective cohort study and Traumatic brain injury.
In his work, Placebo is strongly intertwined with Odds ratio, which is a subfield of Meta-analysis.
His most cited work include:
- A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery (888 citations)
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion (824 citations)
- Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. (810 citations)
What are the main themes of his work throughout his whole career to date?
Dean Fergusson mainly focuses on Internal medicine, Randomized controlled trial, Intensive care medicine, Surgery and Meta-analysis.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Mesenchymal stem cell.
The Randomized controlled trial study which covers Clinical trial that intersects with Protocol.
His Intensive care medicine study frequently draws parallels with other fields, such as Cohort study.
His work is connected to Perioperative and Blood transfusion, as a part of Surgery.
His work focuses on many connections between Blood transfusion and other disciplines, such as Emergency medicine, that overlap with his field of interest in Retrospective cohort study.
He most often published in these fields:
- Internal medicine (43.20%)
- Randomized controlled trial (37.03%)
- Intensive care medicine (21.91%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (43.20%)
- Randomized controlled trial (37.03%)
- Clinical trial (22.29%)
In recent papers he was focusing on the following fields of study:
Dean Fergusson mostly deals with Internal medicine, Randomized controlled trial, Clinical trial, Meta-analysis and Oncology.
His study looks at the relationship between Internal medicine and topics such as Placebo, which overlap with Strictly standardized mean difference, Low molecular weight heparin and Physical therapy.
Randomized controlled trial is a subfield of Surgery that Dean Fergusson explores.
His Clinical trial study incorporates themes from Intervention, Protocol and Intensive care medicine.
His Meta-analysis study combines topics from a wide range of disciplines, such as Stroke, Thrombosis, Systematic review and Animal studies.
His Perioperative research focuses on Retrospective cohort study and how it connects with Blood transfusion and Emergency medicine.
Between 2019 and 2021, his most popular works were:
- Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial (57 citations)
- Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease (47 citations)
- Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis. (34 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
His main research concerns Internal medicine, Clinical trial, Randomized controlled trial, Oncology and Adverse effect.
As part of his studies on Internal medicine, Dean Fergusson often connects relevant areas like Placebo.
His research in Clinical trial intersects with topics in Spontaneous intracerebral hemorrhage, Clinical research, Retrospective cohort study, Family medicine and Intensive care medicine.
His studies deal with areas such as Relative risk, Thrombosis and Disease as well as Randomized controlled trial.
His studies in Oncology integrate themes in fields like Open label, Red blood cell, Transplantation and Red Blood Cell Transfusion.
His Adverse effect research integrates issues from Vascular surgery, Neurology, Phases of clinical research and Systematic review methodology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
